David Feygin395 Fort Washington Ave, New York, NY 10033

2010004, Feb 25, 2010

Oct 27, 2009

12/606724

David Feygin - Glen Rock NJ, US
Chih-Hao Ho - Reston VA, US

LAERDAL DC, INC. - Silver Springs MD

G09B 23/28

434272

The illustrative embodiment is a simulation system for practicing vascular-access procedures without using human subjects. The simulator includes a data-processing system and a haptics interface device. The haptics device provides the physical interface at which an end effector (e.g., medical instrument, such as a needle, catheter, etc.) is manipulated to simulate needle insertion, etc. In accordance with the illustrative embodiment, the haptics device includes a receiver. The receiver receives the end effector when it's inserted by a user into the haptics device. Sensors that are associated with the receiver monitor the motion and position of the end effector, generate signals indicative thereof, and transmit the signals to the data processing system. The signals are processed to determine the effects of manipulation of the end effector. In some embodiments, the signals are processed to determine the various resistive forces that would arise if the user were manipulating a needle/catheter through actual human anatomy. Responsive to this determination, the receiver generates forces that the user experiences as a resistance to continued advance (insertion) of the end effector. Simulated results are displayed by the computer system.

2016003, Feb 4, 2016

Mar 14, 2014

14/776699

- Fanklin Lakes NJ, US
David Feygin - Glen Rock NJ, US
Elizabeth Nelson - Wellesley MA, US
Bart Peterson - Farmington UT, US
Karthik Ranganathan - Singapore, SG
Richard Byrd - Glen Rock NJ, US

BECTON, DICKINSON AND COMPANY - Franklin Lakes NJ

A61M 5/34
A61M 5/142

Smart sensors are employed to determine one or more of drug identification, dose, flow rate, concentration, agglomeration, and degradation and/or other characteristics of drug administration that can be detected via sensing technology. A smart sensor(s) can be coupled to or retrofitted onto injection pen injectors and/or drug delivery cartridges and/or infusion sets or cannulae, enabling infusion sets, pen injector systems or drug delivery cartridges to improve tracking of drug self-administration and stop medication errors that occur primarily through self or automated injection (e.g., due to incorrect or incomplete dosing, excessive dose or rate, incorrect drug, or drug degradation).